Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer [Phase 3]
Phase 3 trial updating maintenance niraparib versus placebo in platinum-sensitive ovarian cancer has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer [Phase 2]
Phase 2 trial update for anlotinib in patients with platinum resistant or refractory ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer [Phase 3]
Phase 3 trial evaluating carboplatin plus paclitaxel with or without continued low-dose paclitaxel in early-stage ovarian cancer completed; …
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel with or without pazopanib in persistent or recurrent ovarian, fallopian tube, or peritoneal cavity cance…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating MESO-CAR T cell therapy for relapsed and refractory epithelial ovarian cancer. Status not disclosed in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 trial of PANVAC-V and PANVAC-F vaccines with sargramostim in advanced cancers (adenocarcinoma, colorectal cancer; other listed con…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy [Phase 2]
Phase 2 clinical trial update for intraperitoneal hyperthermic chemotherapy in several gynecologic and related cancers; current status not s…
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian [Phase 2]
Phase 2 clinical trial update evaluating adoptive cell therapy after a reduced intensity, non-myeloablative lymphodepleting induction in met…
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial investigating ABT-263 as a single agent in women with platinum-resistant or refractory recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer [Phase 3]
A Phase 3 trial comparing two first-line regimens (carboplatin-paclitaxel or oxaliplatin-capecitabine) with or without bevacizumab. The stud…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating TRC105 in recurrent ovarian, fallopian tube, or primary peritoneal carcinoma has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer [Phase 2]
Phase 2 trial update on efficacy and safety of albumin-bound paclitaxel as first-line chemotherapy for ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers [Phase 1]
Phase 1 trial update for a vaccine therapy in epithelial ovarian, fallopian tube, or primary peritoneal cancers; trial completed with result…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients [NA]
This completed clinical trial evaluated whether geriatrician-led interventions can improve chemotherapy delivery in vulnerable elderly oncol…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction [Phase 1, Phase 2]
This Phase 1/2 clinical trial tests best supportive care with either cisplatin or paclitaxel for patients with ovarian cancer, primary perit…
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery [Phase 1]
This update reports the completion of a Phase 1 exploratory study evaluating the folic acid-tubulysin conjugate EC1456 in ovarian cancer pat…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
Phase 3 trial comparing trabectedin plus doxorubicin liposome vs doxorubicin liposome alone in advanced-relapsed epithelial ovarian, primary…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer [Phase 1]
A Phase 1 trial evaluating a combination chemotherapy approach with bone marrow transplantation and peripheral stem cell transplantation for…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer [Phase 2]
Phase 2 study of temsirolimus in combination with bevacizumab in advanced endometrial, ovarian, liver, carcinoid, and pancreatic neuroendocr…
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer [Phase 1]
A Phase 1 clinical trial evaluated the pharmacokinetics, safety, and tolerability of ZL-2306 (niraparib) in patients with ovarian cancer and…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Fermented Wheat Germ Extract in Women With Ovarian Cancer [EARLY_Phase 1]
An early-phase trial evaluating Fermented Wheat Germ Extract in women with ovarian cancer; the study was terminated and results were posted …
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer [Phase 1]
Phase 1 trial update evaluating MRI-guided stereotactic body radiation therapy for ovarian cancer; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer [Phase 1]
This document reports a completed Phase I clinical trial from The Netherlands Cancer Institute evaluating carboplatin-olaparib in combinatio…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018) [Phase 2]
Phase 2 trial update investigating NGR-hTNF in combination with an anthracycline for platinum-resistant ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells [Phase 1, Phase 2]
Clinical trial update for an activated primary natural killer cell therapy showing intent to assess anti-tumor effects in multiple cancers i…